Description
De-nol Tablets 120 mg. №56
Ingredients
De-nol tablets contain 120 mg of bismuth subcitrate. Other inactive ingredients include microcrystalline cellulose, povidone, colloidal anhydrous silica, magnesium stearate, talc, and hypromellose.
Mechanism of Action
De-nol tablets work by forming a protective barrier over the ulcer site, promoting healing, and reducing symptoms. The bismuth subcitrate in De-nol exhibits potent antimicrobial activity against Helicobacter pylori, contributing to the eradication of the bacteria and ulcer healing.
Pharmacological Properties
De-nol tablets have cytoprotective effects on the gastric mucosa, aiding in the prevention of further damage and supporting ulcer healing.
Indications for Use
De-nol tablets are indicated for the treatment of peptic ulcers, gastritis, and Helicobacter pylori infection.
Contraindications
Do not use De-nol tablets if you are allergic to bismuth subcitrate or any other ingredients in the tablets. Consult your healthcare provider before starting De-nol therapy if you have any existing medical conditions or are taking other medications.
Side Effects
Common side effects of De-nol tablets may include [list common side effects here]. Contact your healthcare provider if you experience any severe or persistent side effects.
Usage Instructions
Take one De-nol tablet (120 mg) four times a day. Swallow the tablets whole with a glass of water at least one hour before or two hours after meals. Avoid taking antacids within the same timeframe.
Benefits Compared to Analogues
De-nol tablets offer a comprehensive approach to peptic ulcer management with proven efficacy and safety profiles compared to other similar medications.
Suitable Patient Groups
De-nol tablets are suitable for adults, including the elderly, for the treatment of peptic ulcers and related conditions. It is essential to follow the prescribed dosage and treatment duration.
Storage and Shelf Life
Store De-nol tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the tablets after the specified shelf life.
Packaging Description
De-nol tablets are available in a pack of 56 tablets, each containing 120 mg of bismuth subcitrate. The packaging is designed to maintain the integrity and stability of the tablets.
Clinical Evidence and Proven Effectiveness
De-nol tablets have demonstrated efficacy in treating peptic ulcers and Helicobacter pylori infection. Studies have shown that bismuth subcitrate in De-nol exhibits antimicrobial activity against Helicobacter pylori, aiding in bacterial eradication and ulcer healing.
